Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, potentially opening doors for targeted antibiotic therapies.

Cleveland Clinic is collaborating with Dyania Health, an AI-enabled healthcare data company, to integrate Dyania's Synapsis AI platform across Cleveland Clinic's clinical research enterprise. Synapsis ...

Cleveland Clinic has partnered with CAS, a division of the American Chemical Society specializing in scientific content and knowledge management, to accelerate clinical research — with an initial ...

Columbus, OH; Cleveland, OH, April 7, 2025 – CAS, a division of the American Chemical Society specializing in scientific content and knowledge management, and Cleveland Clinic, an academic health ...

This week, Cleveland Clinic announced that it is scaling Dyania Health’s AI platform across its enterprise to accelerate clinical trial recruitment — and hopefully thereby enable patients to access ...

UNDER EMBARGO UNTIL Tuesday, June 10, 2025, 3 a.m. EDT, CLEVELAND: A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight loss in ...

Cleveland Clinic is establishing an emerging pathogens research center that will use data analytics from patient medical records to support the development of new treatments and vaccines. The Center ...